Filter
8788
Filtered Results: 8788
Text search:
patient
information
Featured
Recommendations
852
New Publications
2202
Language
Document type
No document type
4872
Studies & Reports
1250
Guidelines
1228
Manuals
463
Strategic & Response Plan
284
Fact sheets
259
Training Material
171
Situation Updates
107
Resource Platforms
47
Brochures
42
Infographics
37
Online Courses
19
Videos
8
App
1
Countries / Regions
India
430
Global
294
Kenya
231
South Africa
224
Sierra Leone
209
Liberia
186
Western and Central Europe
172
Ethiopia
167
Nigeria
160
Uganda
154
Congo, Democratic Republic of
151
Africa
129
Malawi
118
Tanzania
117
Rwanda
112
Nepal
110
Latin America and the Carribbean
106
Senegal
101
Zambia
100
Myanmar / Burma
94
Ghana
93
Bangladesh
92
Germany
83
Syria
83
Guinea
82
Burkina Faso
78
Haiti
77
Ukraine
76
Namibia
63
Eastern Europe
61
West and Central Africa
60
Benin
58
Philippines
57
Cambodia
52
Mozambique
50
East and Southern Africa
50
South–East Asia Region
50
Zimbabwe
47
South Sudan
47
Cameroon
46
Lesotho
46
Russia
44
Asia
42
Middle East and North Africa
41
Brazil
39
Mali
37
Madagascar
37
Indonesia
34
Botswana
32
Eastern Europe and Central Asia
30
Côte d’Ivoire / Ivory Coast
25
Central African Republic
25
Yemen
23
Venezuela
23
USA
21
Eswatini/ Swaziland
21
Colombia
19
Niger
17
Togo
15
Pakistan
15
Western Pacific Region
15
Tajikistan
15
Peru
14
Somalia
13
Afghanistan
13
Chad
13
Angola
13
Thailand
12
Sudan
12
Vietnam
12
Iraq
11
Lebanon
11
Albania
11
Georgia
11
Sri Lanka
10
Laos
10
Jordan
9
China
9
Bolivia
9
Moldova
9
United Kingdom
9
Argentina
8
Ecuador
8
Chile
8
Palestine
8
Southern Africa
8
Burundi
7
North America
7
Spain
7
Guinea-Bissau
6
Turkey
6
North Macedonia
6
Switzerland
6
Mexico
6
France
6
Morocco
5
Paraguay
5
Armenia
5
Canada
5
Jamaica
5
Gambia
4
Hungary
4
Bhutan
4
Poland
4
Congo-Brazzaville
4
Kyrgyzstan
4
Kazakhstan
4
Ireland
3
Papua New Guinea
3
Serbia
3
Honduras
3
El Salvador
3
Greece
3
Libya
3
Italy
3
Timor Leste/ East Timor
3
Romania
3
Uzbekistan
3
Saudi Arabia
2
Malaysia
2
Singapore
2
Guatemala
2
Fiji
2
Bulgaria
2
Estonia
2
Lithuania
2
Slovakia
2
Iran
2
Australia
2
Gabon
2
Belgium
2
Mauritius
2
Tunisia
2
Portugal
2
Egypt
1
Mauritania
1
Austria
1
Nicaragua
1
Other region
1
Luxembourg
1
Solomon Islands
1
North Korea
1
Djibouti
1
Mongolia
1
Qatar
1
Turkmenistan
1
Japan
1
Denmark
1
Maldives
1
Norway
1
South Korea
1
Belarus
1
French Guyana
1
Israel
1
Latvia
1
United Arab Emirates
1
Authors & Publishers
Publication Years
Category
Countries
3248
Clinical Guidelines
783
Public Health
466
Women & Child Health
367
Key Resources
274
Capacity Building
197
Pharmacy & Technologies
117
Annual Report MEDBOX
2
Toolboxes
COVID-19
962
Mental Health
706
HIV
648
TB
561
Ebola
417
Caregiver
319
Rapid Response
311
AMR
300
NTDs
233
Pharmacy
201
Refugee
193
NCDs
186
Conflict
176
Disability
171
Planetary Health
133
Global Health Education
86
Cholera
80
Zika
66
Natural Hazards
64
Specific Hazards
53
Polio
44
Health Financing Toolbox
38
Social Ethics
29
Typhoon
3
South Sudan
1
Health Financing
1
24 April 2020
Policy considerations
for the WHO European Region
This document provides key considerations for Member States to help them to decide on the modulation
of large-scale restrictive public health measures
(i.e. movement restrictions and large-scale physical distancing), while at the...
Infection prevention and control practices need to be implemented to guarantee the safety of healthcare workers and patients in healthcare settings, it is fundamental to prevent cross contamination and containment of spread of COVID 19. As of the da...
N95 or equivalent respirators are single-use personal protective equipment (PPE) designed for use by health workers that provide direct care to patients with diseases transmitted by aerosols or during aerosol generating procedures (AGP) for ... with acute respiratory disease, as is the case of COVID-19. • Given the current shortage of N95 and equivalent respirators, the World Health Organization (WHO) has suggested the possibility of their extended use by the same individual for up to 6 hours or the reprocessing of respirators when necessary.
The package provides practical, concise yet crucial information about the impact of COVID-19 on daily teaching practices as well as tips and suggestions to improve safety, well-being and learning, with students in face-to-face or remote settings.
...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging partic...
This document offers tools to help journalists practice responsible coverage of the pandemic using evidence-based information. It also proposes ways to approach coverage and encourages journalists to provide advice and solutions that can help reduce...
This informational guide presents six strategies for immunization coordinators.
It includes tangible actions to promote confidence, communication, and uptake of COVID-19 vaccine, which can help support confidence among providers and ....
The 2019 ANA’s Principles for Nurse Staffing, Third Edition, identifies major elements needed to achieve appropriate nurse staffing, which enhances the delivery of safe, quality health care. These principles are grounded in the substantive and growing body of evidence that demonstrates the link be...
second edition
Included more self-measured blood pressure (SMBP)-focused content with tools and resources.
Showcased more tools to find patients with potentially undiagnosed HTN.
Added new strategies that focus on chronic kidney disease testin...
This e-course will guide you through the essentials of latest existing WHO guidelines and policy recommendations on drug-resistant TB. You will also learn more about the rationale behind the WHO recommendations for the management of DR-TB, implementation considerations for different regimens for eli...
Ongoing Living Update of COVID-19 Therapeutic Options: Summary of Evidence, Rapid Review 22 February 2022
recommended
This document includes the results of a rapid systematic review of current available literature. The information included in this review reflects the evidence as of the date posted in the document. In recognition of the fact that there are numerous ...
Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline
recommended
This second edition of the Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline provides the most up to date technical guidance on mask use in community settings in the context of COVID-19.
In this edition, new ... includes updated mask recommendations for children in community settings including updated age specific recommendations, statements for children with disabilities and those at high risk for complications related to COVID-19 infection. Updated implementation considerations for mask use in school settings are also included.
This living guideline is being published using the MAGICApp online publishing platform https://app.magicapp.org/#/guideline/Lr2a8L , as well as in PDF copy on the WHO website.
This report reviews and analyses the Affordable Medicines Programme, which was introduced in Ukraine in April 2017 to provide patients with improved access to 23 outpatient medicines for the treatment of chronic noncommunicable diseases. The evaluat...
The guide is suitable and can be used for the following audiences:
1. nurses and other trained healthcare workers who can use this manual as a self-study tool and then incorporate its guidance into their practice;
2. governmental and non-governmental employers of lay and professional TB treatment ...
Policy Brief November 2021 Available in English, Spanish and Portuguese
The COVID-19 pandemic has fueled the ongoing antimicrobial resistance (AMR) global crisis due to the increase in the use of antibiotics to treat COVID-19 patients, disruptions...
This regional report on the situation of tuberculosis (TB) in the Americas contains information from 2019, provided by the countries of the Region through the World Health Organization TB data collection system. These data have been consolidated and...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The ...-centred platform aims to facilitate clinical research, provide a forum for technical discussions, develop a critical mass of expertise, and strengthen institutional research capacities. In addition, it identifies and reviews priority needs, works towards standardization of methodology to assess drug efficacy and reviews alternatives for using current approved drugs (new schemes, doses, combination) and special scenarios (resistance).
The purpose of this document is to contribute to improved recognition of Buruli
ulcer (Mycobacterium ulcerans infection) and encourage greater efforts in detecting
cases at an early stage of infection.Today, patients can be cured with antibiotics ...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in ... with non-severe COVID-19
The guidance includes updated risk rates for hospital admission in patients with non-severe COVID-19.
The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients.
This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines:
**High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%.
**Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%.
Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk.
Review of COVID-19 treatments for people with non-severe COVID-19
WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022.
If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead.
WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission.
For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol.
WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials.
The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials.
This paper explores the angles and opportunities of digital health, with a look
at digital innovation and its potential to support patients with circulatory diseases.
In reviewing developments in the field, current applications as well as gaps, th...
